Author

Qihong Zhao

Peter MacCallum Cancer CentrePrimary ORCID profile (0000-0003-0542-7954 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Qihong ZhaoiD1 paper · Bristol-Myers Squibb (United States)

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Amanda B. SpurdleiD· 1 shared Amy E. McCart ReediD· 1 shared Anita Rohini SkandarajahiD· 1 shared Cristina FortuñoiD· 1 shared Dilanka L De SilvaiD· 1 shared Geoffrey John LindemaniD· 1 shared Georgina E. HollwayiD· 1 shared Gregory Bruce ManniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Amanda B. SpurdleORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Integrating breast tumor homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification

Cristina Fortuño, Jia Zhang, Lambros T. Koufariotis, Georgina E. Hollway, Scott Wood, John V. Pearson, Peter T. Simpson, Sunil R. Lakhani, Amy E. McCart Reed, Heather Thorne, Gregory Bruce Mann, Anita Rohini Skandarajah, Lisa Devereux, Qihong Zhao, Dilanka L De Silva, , Nicola Waddell

This paper integrates tumor homologous recombination deficiency status with germline BRCA1 and BRCA2 variant classification to improve pathogenicity prediction.

medRxiv · Jun 12, 2025 · PreprintGenetic & Genomic Medicine